Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta M Alonso

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Cancer Cell|October 6, 2023
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memoryIker Ausejo-Mauleon, Sara Labiano, Daniel de la Nava, et al.
Nature Medicine|May 5, 2015
Functionally defined therapeutic targets in diffuse intrinsic pontine gliomaCatherine S Grasso, Yujie Tang, Nathalene Truffaux, et al.
The New England Journal of Medicine|June 29, 2022
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine GliomaJaime Gállego Pérez-Larraya, Marc Garcia-Moure, Sara Labiano, et al.
Nature Medicine|July 21, 2025
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trialFarshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Nature Medicine|July 8, 2015
Functionally defined therapeutic targets in diffuse intrinsic pontine gliomaCatherine S Grasso, Yujie Tang, Nathalene Truffaux, et al.
Nature Medicine|May 15, 2023
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trialFarshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Nature Medicine|January 8, 2025
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trialNicholas A Vitanza, Rebecca Ronsley, Michelle Choe, et al.
Acta Neuropathologica|July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroupFlorence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.
Neuro-Oncology|May 8, 2024
Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profileGunther Nussbaumer, Martin Benesch, Yura Grabovska, et al.
Cancer Cell|December 1, 2023
A road map for the treatment of pediatric diffuse midline gliomaCarl Koschmann, Wajd N Al-Holou, Marta M Alonso, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Cancer Cell|October 6, 2023
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memoryIker Ausejo-Mauleon, Sara Labiano, Daniel de la Nava, et al.
Nature Medicine|May 5, 2015
Functionally defined therapeutic targets in diffuse intrinsic pontine gliomaCatherine S Grasso, Yujie Tang, Nathalene Truffaux, et al.
The New England Journal of Medicine|June 29, 2022
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine GliomaJaime Gállego Pérez-Larraya, Marc Garcia-Moure, Sara Labiano, et al.
Nature Medicine|July 21, 2025
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trialFarshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Nature Medicine|July 8, 2015
Functionally defined therapeutic targets in diffuse intrinsic pontine gliomaCatherine S Grasso, Yujie Tang, Nathalene Truffaux, et al.
Nature Medicine|May 15, 2023
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trialFarshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Nature Medicine|January 8, 2025
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trialNicholas A Vitanza, Rebecca Ronsley, Michelle Choe, et al.
Acta Neuropathologica|July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroupFlorence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.
Neuro-Oncology|May 8, 2024
Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profileGunther Nussbaumer, Martin Benesch, Yura Grabovska, et al.
Cancer Cell|December 1, 2023
A road map for the treatment of pediatric diffuse midline gliomaCarl Koschmann, Wajd N Al-Holou, Marta M Alonso, et al.
Pageof 11